REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a webcast to discuss new interim functional data from the Phase I/II AFFINITY DUCHENNE® trial of RGX-202, the company's next-generation ...

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future ...

NIH-funded breakthrough could enable targeted therapies for many neurological disorders.

Exercising two to four times a week has become part of Devdan Devaraj’s routine, with the five-year-old taking part in sports ...

Scientists working at the NIH’s BRAIN Initiative have created new viral vectors that one day could lead to gene therapies for ...

Chandrapur: Ayush was born on January 26, 2025, at the govt hospital in Chandrapur. For the first few days, nothing seemed unusual. But when he showed.

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord ...

Rainbow Children’s Hospital (RCH( on Wednesday said it has successfully administered ‘gene therapy’ to a child diagnosed with Spinal Muscular Atrophy (SMA), marking the eighth such treatment carried ...